ProShare Advisors LLC Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

ProShare Advisors LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 460,247 shares of the medical equipment provider’s stock after acquiring an additional 77,926 shares during the period. ProShare Advisors LLC owned 0.13% of Intuitive Surgical worth $240,231,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in ISRG. Capital Investment Advisors LLC lifted its stake in Intuitive Surgical by 15.6% in the fourth quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider’s stock worth $469,000 after purchasing an additional 121 shares during the last quarter. Miracle Mile Advisors LLC increased its holdings in Intuitive Surgical by 7.9% during the fourth quarter. Miracle Mile Advisors LLC now owns 1,948 shares of the medical equipment provider’s stock valued at $1,017,000 after buying an additional 143 shares during the period. Signal Advisors Wealth LLC grew its holdings in Intuitive Surgical by 12.2% in the fourth quarter. Signal Advisors Wealth LLC now owns 1,594 shares of the medical equipment provider’s stock worth $832,000 after purchasing an additional 173 shares during the last quarter. Accurate Wealth Management LLC grew its holdings in Intuitive Surgical by 6.7% in the fourth quarter. Accurate Wealth Management LLC now owns 5,978 shares of the medical equipment provider’s stock worth $3,273,000 after purchasing an additional 373 shares during the last quarter. Finally, SeaCrest Wealth Management LLC grew its holdings in Intuitive Surgical by 2.2% in the fourth quarter. SeaCrest Wealth Management LLC now owns 1,982 shares of the medical equipment provider’s stock worth $1,035,000 after purchasing an additional 42 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $565.94 on Thursday. The company has a 50 day simple moving average of $502.26 and a 200-day simple moving average of $535.79. The company has a market capitalization of $202.84 billion, a P/E ratio of 88.29, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1 year low of $386.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter last year, the firm earned $1.50 EPS. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the topic of a number of research analyst reports. Leerink Partners boosted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. CICC Research initiated coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. Piper Sandler decreased their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research report on Wednesday, April 23rd. Finally, Royal Bank of Canada reduced their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $598.95.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This trade represents a 68.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,680 shares of company stock worth $16,854,345 in the last 90 days. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.